You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Post-Essential Thrombocythemia Myelofibrosis (PET-MF)

Showing 26 - 50 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Primary Myelofibrosis, Post-polycythemia Vera Myelofibrosis, Post-essential Thrombocythemia Myelofibrosis Trial in Worldwide

Recruiting
  • Primary Myelofibrosis
  • +2 more
  • Birmingham, Alabama
  • +151 more
Aug 22, 2022

Primary Myelofibrosis Trial (Pacritinib)

Withdrawn
  • Primary Myelofibrosis
  • Pacritinib
  • (no location specified)
May 3, 2021

Primary Myelofibrosis (PMF), Post-Polycythemia Vera Myelofibrosis (Post-PV-MF), Post-Essential Thrombocythemia Myelofibrosis

Recruiting
  • Primary Myelofibrosis (PMF)
  • +2 more
  • Glendale, California
  • +28 more
May 5, 2022

Primary Myelofibrosis, Post-Polycythemia Vera Myelofibrosis, Post-Essential Thrombocythemia Myelofibrosis Trial in Worldwide

Completed
Has Results
  • Primary Myelofibrosis
  • +4 more
  • Scottsdale, Arizona
  • +21 more
Jan 18, 2021

Primary Myelofibrosis, Post-Polycythemia Vera Myelofibrosis, Post- Essential Thrombocythemia Myelofibrosis Trial in Worldwide

Completed
Has Results
  • Primary Myelofibrosis
  • +2 more
  • Phoenix, Arizona
  • +61 more
May 5, 2022

Primary Myelofibrosis (PMF), Post-polycythemia Vera (Post-PV) Myelofibrosis, Postessential Thrombocythemia (Post-ET)

Completed
Has Results
  • Primary Myelofibrosis (PMF)
  • +2 more
  • Phoenix, Arizona
  • +12 more
Jan 12, 2021

A Prospective, Two-arm, Non-interventional Study of JAKAVI® in

Active, not recruiting
  • Primary Myelofibrosis
  • +2 more
  • Jakavi
  • Aachen, Germany
    Novartis Investigative Site
Sep 6, 2021

Study (MOST)

Completed
  • MPN (Myeloproliferative Neoplasms)
    • Huntsville, Alabama
    • +115 more
    May 11, 2022

    Primary Myelofibrosis, Post-Polycythemia Vera, Post-Essential Thrombocytopenia Trial in United States (Panobinostat)

    Terminated
    Has Results
    • Primary Myelofibrosis
    • +2 more
    • Scottsdale, Arizona
    • +8 more
    Jul 9, 2021

    Myelofibrosis, Myelodysplastic Syndrome, Myelodysplastic/Myeloproliferative Tumor Overlap Syndrome Trial in Worldwide

    Recruiting
    • Myelofibrosis
    • +5 more
    • Birmingham, Alabama
    • +27 more
    Oct 17, 2022

    Myelofibrosis, Primary Myelofibrosis (PMF), Post-polycythemia Vera Myelofibrosis Trial in Hangzhou (Jaktinib HCl tablets)

    Recruiting
    • Myelofibrosis
    • +3 more
    • Jaktinib hydrochloride tablets
    • Hangzhou, Zhejiang, China
      The First Affiliated Hospital of Medical School of Zhejiang Univ
    Jun 11, 2021

    Chronic Phase Myelofibrosis, Primary Myelofibrosis, Post-essential Thrombocythemia Myelofibrosis Trial in Boston, Bronx, New

    Completed
    Has Results
    • Chronic Phase Myelofibrosis
    • +3 more
    • Boston, Massachusetts
    • +2 more
    May 27, 2021

    Myelofibrosis, Polycythemia Vera, Thrombocythemia Trial in Worldwide (itacitinib)

    Active, not recruiting
    • Myelofibrosis
    • +2 more
    • New Orleans, Louisiana
    • +20 more
    Aug 25, 2022

    Essential Thrombocythemia, Primary Myelofibrosis, Fibrotic Stage, Primary Myelofibrosis, Prefibrotic Stage Trial in Doha

    Unknown status
    • Essential Thrombocythemia
    • +2 more
    • Diagnostic (18F-FLT PET/CT)
    • Doha, Qatar
      National Center for Cancer Care & Research (NCCCR)
    Sep 27, 2020

    Ruxolitinib in Patients With Myelofibrosis

    Not yet recruiting
    • Myelofibrosis
    • (no location specified)
    Feb 28, 2023

    Myelofibrosis Trial in Stanford, Ann Arbor (Idelalisib, Ruxolitinib)

    Terminated
    Has Results
    • Myelofibrosis
    • Stanford, California
    • +1 more
    Aug 31, 2020

    Myelofibrosis Transformation in Essential Thrombocythemia, Polycythemia Vera, Post-Polycythemic Myelofibrosis Phase, Primary

    Recruiting
    • Myelofibrosis Transformation in Essential Thrombocythemia
    • +2 more
    • Elotuzumab
    • Questionnaire Administration
    • Houston, Texas
      M D Anderson Cancer Center
    Feb 17, 2021

    Myelofibrosis Trial in Rochester, Firenze (APLIDIN (plitidepsin))

    Completed
    Has Results
    • Myelofibrosis
    • APLIDIN (plitidepsin)
    • Rochester, Minnesota
    • +1 more
    Sep 17, 2020

    Primary Myelofibrosis (PMF), Post-Polycythemia Vera MF (Post-PV-MF), Post-Essential Thrombocythemia MF (Post-ET-MF) Trial in

    Recruiting
    • Primary Myelofibrosis (PMF)
    • +2 more
    • Birmingham, Alabama
    • +155 more
    Aug 12, 2022

    Myelofibrosis, Primary Myelofibrosis, Post-polycythemia Vera Myelofibrosis Trial in United States (PU-H71, Ruxolitinib)

    Terminated
    • Myelofibrosis
    • +3 more
    • New Haven, Connecticut
    • +9 more
    Oct 19, 2020

    Myelofibrosis, Primary Myelofibrosis, Post Essential Thrombocythemia Myelofibrosis Trial in Worldwide (parsaclisib, ruxolitinib,

    Recruiting
    • Myelofibrosis
    • +3 more
    • Anchorage, Alaska
    • +172 more
    Dec 1, 2022

    Myelofibrosis Trial in United States (Simtuzumab, Ruxolitinib)

    Completed
    Has Results
    • Myelofibrosis
    • Scottsdale, Arizona
    • +6 more
    Jun 17, 2020

    Primary Myelofibrosis (PMF), Post-polycythemia Vera (Post-PV), Post-essential Thrombocythemia Myelofibrosis (Post-ET MF) Trial

    Completed
    • Primary Myelofibrosis (PMF)
    • +2 more
    • Los Angeles, California
    • +47 more
    Apr 1, 2020

    Myelofibrosis, Primary Myelofibrosis, Post-polycythemia Vera Myelofibrosis Trial in Worldwide (Pelabresib, Ruxolitinib, Placebo)

    Recruiting
    • Myelofibrosis
    • +3 more
    • Birmingham, Alabama
    • +148 more
    Oct 10, 2022

    Primary Myelofibrosis, Post-polycythemia Vera Myelofibrosis, Post-essential Thrombocythemia Myelofibrosis Trial in Worldwide

    Active, not recruiting
    • Primary Myelofibrosis
    • +2 more
    • Phoenix, Arizona
    • +166 more
    Jan 27, 2022